Basics Lyell Immunopharma, Inc. IPO Date: June 17, 2021 Sector: Healthcare Industry: Biotech Market Cap: $535.76M Activated in VL: True Average Daily Range Avg Daily Range: $0.23 | 4.19% Avg Daily Range (30 D): $0.83 | 4.21% Avg Daily Range (90 D): $0.60 | 3.77% Institutional Daily Volume Avg Daily Volume: .67M Avg Daily Volume (30 D): .03M Avg Daily Volume (90 D): .03M Trade Size Avg Trade Size (Sh.): 124 Avg Trade Size (Sh.) (30 D): 32 Avg Trade Size (Sh.) (90 D): 46 Institutional Trades Total Inst.Trades: 342 Avg Inst. Trade: $1.97M Avg Inst. Trade (30 D): $.55M Avg Inst. Trade (90 D): $1.28M Avg Inst. Trade Volume: .02M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.3M Avg Closing Trade (30 D): $.55M Avg Closing Trade (90 D): $1.28M Avg Closing Volume: 28.67K     News Dec 7, 2025 @ 9:30 PM Lyell Immunopharma Presents New Clinical Data from... Source: Lyell Immunopharma Nov 3, 2025 @ 2:00 PM Lyell Announces Two Oral Presentations from the Ph... Source: Lyell Immunopharma, Inc. Jul 29, 2025 @ 7:46 PM Biotech Underdogs Line Up for Pivotal Shots at Gam... Source: Prnewswire Jun 23, 2025 @ 9:00 PM Lyell Immunopharma to Participate in the H.C. Wain... Source: N/A May 1, 2025 @ 1:00 PM Lyell Immunopharma Announces Oral Presentation of ... Source: Lyell Immunopharma, Inc. Financials   TTM Q3 2025 Q2 2025 Basic EPS $2.14 $-2.13 $-2.89 Diluted EPS $2.14 $-2.13 $-2.89 Revenue $ .04M $ .02M $ .01M Gross Profit $ $ $ Net Income / Loss $ -325.66M $ -38.85M $ -42.68M Operating Income / Loss $ -342.91M $ -37.25M $ -47.14M Cost of Revenue $ $ $ Net Cash Flow $ 24.57M $ 24.77M $ -21.63M PE Ratio 13.06     Splits Jun 02, 2025:   1:20